Clinical Outcomes and Risk Factors for Adverse Events Associated With Endoscopic Ultrasound-Guided Drainage of Postoperative Pancreatic Fluid Collections Following Distal Pancreatectomy

Hepatology

Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis

Lancet Gastroenterol Hepatol

Celsa C, Pennisi G, Tulone A, Ciancimino G, Vaccaro M, Pecorella F, Di Maria G, Enea M, Midiri F, Mantovani A, Targher G, Krag A, Rinella ME, Cammà C, Petta S

doi: 10.1016/S2468-1253(25)00188-8

Further Publications

Clinical Success Impacts Overall Survival in Patients Undergoing Palliation for Malignant Gastric Outlet Obstruction Using Enteral Stents or Endoscopic Ultrasound Guided Gastroenterostomy

J Gastroenterol Hepatol

Mahajan A, Sundaram S, Puri R, Shravan GH, Mane K, Kale A, Patkar S, Goel M, Shrikhande S, Chaudhari V, Patil P, Mehta S

doi: 10.1111/jgh.70066

Gastrointestinal Cancer

Immune-related Adverse Events are Associated with Improved Outcomes after Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Am J Gastroenterol

Hwang SY, Rezaee-Zavareh MS, Attia AM, Kaymen EA, Tran N, Abou-Alfa GK, Parikh ND, Singal AG, Yang JD

doi: 10.14309/ajg.0000000000003546

Gastrointestinal Cancer

Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trial

Lancet Gastroenterol Hepatol

Schouten TJ, Prinsze KJ, Henry AC, Daamen LA, Besselink MG, Bonsing BA, Bosscha K, Busch OR, Cirkel GA, van Dam RM, van Eijck CH, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IHJT, Kazemier G, Liem MSL, de Meijer VE, Sven D Mieog J, Patijn GA, Roos D, Schreinemakers JMJ, Stommel MWJ, Wit F, van Werkhoven CH, Molenaar IQ, Smits FJ, van Santvoort HC, Dutch Pancreatic Cancer Group

doi: 10.1016/S2468-1253(25)00367-X

Hepatology

Longitudinal Changes in Cardiometabolic Risk Factors are Associated with Changes in Liver Stiffness in Adults with MASLD

J Hepatol

Dukewich M, Wilson LA, Dodge JL, Yuan L, Hameed B, Yates KP, Loomba R, Neuschwander-Tetri BA, Mack W, Terrault N, NASH Clinical Research Network

doi: 10.1016/j.jhep.2026.02.002

Further Publications

Changing the Flow: How EUS-Guided Drainage is Reshaping the Management of Distal Malignant Biliary Obstruction

United European Gastroenterol J

Fritzsche JA, de Vries I, van Hooft JE, Voermans RP, van Wanrooij RLJ

doi: 10.1002/ueg2.70166

Gastrointestinal Cancer

Risk factors for pancreatic cancer among non-smokers and non-drinkers of alcohol in the Women's Health Initiative

Cancer Epidemiol Biomarkers Prev

Peila R, Manson JE, Rohan TE

doi: 10.1158/1055-9965.EPI-25-0745

HepatitisHepatology

Cardiometabolic Risk Factors Impair Recompensation and Survival in Alcohol-Associated Liver Disease

Clin Gastroenterol Hepatol

Torosian K, Díaz LA, Tesfai K, Wu W, Cooper KM, Devuni D, Mohamed K, Lim N, Rajan A, Cheung A, Wang K, Shroff H, Kwong A, Ajmera V

doi: 10.1016/j.cgh.2026.02.001

Hepatology

Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data

Hepatology

Ng WH, Yeo YH, Kim H, Seki E, Rees J, Ma KS, Moylan CA, Rodriquez LM, Abdelmalek M, Villanueva A, Noureddin M, Yang JD

doi: 10.1097/HEP.0000000000001333

Related content

Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis

Clinical Success Impacts Overall Survival in Patients Undergoing Palliation for Malignant Gastric Outlet Obstruction Using Enteral Stents or Endoscopic Ultrasound Guided Gastroenterostomy

Immune-related Adverse Events are Associated with Improved Outcomes after Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trial

Longitudinal Changes in Cardiometabolic Risk Factors are Associated with Changes in Liver Stiffness in Adults with MASLD

Changing the Flow: How EUS-Guided Drainage is Reshaping the Management of Distal Malignant Biliary Obstruction

Risk factors for pancreatic cancer among non-smokers and non-drinkers of alcohol in the Women's Health Initiative

Cardiometabolic Risk Factors Impair Recompensation and Survival in Alcohol-Associated Liver Disease

Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data